Table 2.

Clinical study of c-kit+ resident cardiac stem/progenitor cell therapy in heart failure

Study	Design	Number of patients	Method of delivery	Cell dose	Follow-up period	Results	Reported side effects of therapy
Bolli et al. (SCIPIO) [40••]	Open-label, randomized, controlled study	Control (n = 7); cell-treated (n = 16)	Intracoronary	1 million cells	4 mo and 12 mo	↑ LVEF ↓ Infarct size ↓ NYHA class	No major complications